MBX Accounts Payable vs Capital Lease Obligations Analysis
| MBX Stock | 18.50 1.99 12.05% |
MBX Biosciences, financial indicator trend analysis is infinitely more than just investigating MBX Biosciences, Common recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MBX Biosciences, Common is a good investment. Please check the relationship between MBX Biosciences, Accounts Payable and its Capital Lease Obligations accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MBX Biosciences, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Accounts Payable vs Capital Lease Obligations
Accounts Payable vs Capital Lease Obligations Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MBX Biosciences, Common Accounts Payable account and Capital Lease Obligations. At this time, the significance of the direction appears to have pay attention.
The correlation between MBX Biosciences,'s Accounts Payable and Capital Lease Obligations is -0.99. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Capital Lease Obligations in the same time period over historical financial statements of MBX Biosciences, Common, assuming nothing else is changed. The correlation between historical values of MBX Biosciences,'s Accounts Payable and Capital Lease Obligations is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of MBX Biosciences, Common are associated (or correlated) with its Capital Lease Obligations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Lease Obligations has no effect on the direction of Accounts Payable i.e., MBX Biosciences,'s Accounts Payable and Capital Lease Obligations go up and down completely randomly.
Correlation Coefficient | -0.99 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents MBX Biosciences, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of MBX Biosciences, Common are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Capital Lease Obligations
MBX Biosciences, Common capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to MBX Biosciences, asset purchases. For example, MBX Biosciences, can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as MBX Biosciences, control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Most indicators from MBX Biosciences,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MBX Biosciences, Common current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MBX Biosciences, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Selling General Administrative is likely to drop to about 5.8 M in 2024. Issuance Of Capital Stock is likely to drop to about 57.8 M in 2024
| 2010 | 2023 | 2024 (projected) | Total Operating Expenses | 25.2M | 35.3M | 33.3M | Research Development | 21.4M | 28.5M | 27.5M |
MBX Biosciences, fundamental ratios Correlations
Click cells to compare fundamentals
MBX Biosciences, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MBX Stock Analysis
When running MBX Biosciences,'s price analysis, check to measure MBX Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences, is operating at the current time. Most of MBX Biosciences,'s value examination focuses on studying past and present price action to predict the probability of MBX Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences,'s price. Additionally, you may evaluate how the addition of MBX Biosciences, to your portfolios can decrease your overall portfolio volatility.